Imfinzi (durvalumab) - AstraZeneca
tiragolumab (RG6058) - Roche
CC003 - Chupu Chuang (Wuhan) Pharmaceutical Technology
Tecentriq (atezolizumab) - Roche
http://www.ncbi.nlm.nih.gov/pubmed/41982692
 
Jiaying Deng; Zhengfei Zhu
 
Apr 15, 2026
 
Prev Next